Knight Therapeutics (KHTRF) Rating Reiterated by Raymond James  Baseball Daily News

Knight Therapeutics (OTCMKTS:KHTRF)’s stock had its “buy” rating restated by equities researchers at Raymond James in a report released on Wednesday, …